INFLUENCE OF ANTIARRHYTHMIC DRUGS ON THE SPECTRAL ANALYSIS OF HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION

Ekaterina P. Popova; O. T Bogova; S. N Puzin; I. S Matsokin; A. A Gadzhimagomedova; D. A Sychev; V. P Fisenko

doi:10.18821/1560-9537-2018-21-1-101-104

Medical and Social Expert Evaluation and Rehabilitation ›› 2018, Vol. 21 ›› Issue (1-2) : 101 -104. DOI: 10.18821/1560-9537-2018-21-1-101-104

Articles

research-article

INFLUENCE OF ANTIARRHYTHMIC DRUGS ON THE SPECTRAL ANALYSIS OF HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION

Author information +

History +

PDF

Abstract

The use of the spectral analysis of the heart rate variability to assess the effectiveness of therapy is of great attention of researchers and doctors. This method allows you to get knowledge of the influence of the autonomic nervous system on the heart activity, which is an important factor for the manifestation of the effects of antiarrhythmic drugs. In this study, we studied the effect of antiarrhythmic drugs of class III amiodarone and sotalol on spectral indices of the heart rate variability in patients with atrial fibrillation. The power of slow frequencies prevailed in the structure of the spectrum with the introduction of amiodarone and sotalol. This suggests that the sympathetic nervous system have a predominant influence on the heart.

Keywords

spectral analysis of heart rate variability / antiarrhythmic drugs class III / amiodarone / sotalol / patients / atrial fibrillation

Cite this article

Download citation ▾

Ekaterina P. Popova, O. T Bogova, S. N Puzin, I. S Matsokin, A. A Gadzhimagomedova, D. A Sychev, V. P Fisenko. INFLUENCE OF ANTIARRHYTHMIC DRUGS ON THE SPECTRAL ANALYSIS OF HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION. Medical and Social Expert Evaluation and Rehabilitation, 2018, 21(1-2): 101-104 DOI:10.18821/1560-9537-2018-21-1-101-104

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Баевский Р.М., Кириллов О.И., Клецкин С.З. Математический анализ изменений сердечного ритма при стрессе. М.: Наука; 1984.

[2]	Кринский В.И., Михайлов А.С. Автоволны. М.; Знание; 1984.

[3]	Явелов И.С., Грацианский Н.А., Зуйков Ю.А. Вариабельность ритма сердца при острых коронарных синдромах: значение для оценки прогноза заболевания. Обзор. Кардиология. 1997; (2): 61-9.

[4]	Akselrod S., Gordon D., Madwed J.B., Snidman N.C., Shannon D.C., Cohen R.J. Hemodynamic regulation: Investigation by spectral analysis. Am. J. Physiol. 1985; 249: 867-75.

[5]

Kirchhof P., Breithardt G., Bax J., Benninger G., Blomstrom-Lundqvist C., Boriani G. et al., A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference. Europace. 2016; 18(1): 37-50.

[6]	Wang Z., Page P., Nattel S. Mechanism of flecainide’s antiarrhythmic action in experimental atrial fibrillation. Circ. Res. 1992; 71(2): 271-87.

[7]	Jaïs P., Haïssaguerre M., Shah D.C., Chouairi S., Gencel L., Hocini M. et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation. 1997; 95(3): 572-6.

[8]	Task Forse of the European Society of Cardiology and the North American Society of Paciety of Pacing and Electrophysiology. Heart rate variability. Standarts of measurements, physiological interpretation and clinical use. Circulation. 1996; 93: 1043-65.

[9]	Баевский Р.М., Иванов И.И., Чирейкин Л.В. и др. Анализ вариабельности сердечного ритма при использовании различных электрокардиографических систем (методические рекомендации). Вестник аритмологии, 2001; (24): 65-87.

[10]	Флейшман А.Н., Филимонов С.Н., Климина Н.В. Новый способ подбора препаратов для лечения артериальной гипертонии на основе спектрального анализа вариабельности ритма сердца. Тер. архив. 2001; (12): 33-9.

[11]	Akselrod S. Components of heart rate variability. Basis studies. In: Heart Rate Variability. Eds M.Malik, A.J.Camm.- Armonk. N.-Y. Futura Pablishity. Comp.Inc. 1995, 147-63.

[12]	Lok N.S., Lau C.P. Abnormal vasovagal reaction, autonomic function, and heart rate variability in patients with paroxysmal atrial fibrillation. Pacing Clin.Electrophysiol.1998, 21(2): 386-95.

[13]	Gal P., Elvan A., Rossi P., Schauerte P., Blomström-Lundqvist C., Sciaraffia E. et al. Effect of parasympathetic nerve stimulation on atrial and atrioventricular nodal electrophysiological characteristics. Int. J. Cardiol. 2016, 205: 83-5.

[14]	Искендеров БГ., Рахматуллов ФК. Структурные и электрофизиологические показатели функции сердца при пароксизмальной мерцательной аритмии. Тер. aрхив. 2001, 12: 52-6.

[15]	Hohendanner F., Heinzel F. R, Blaschke F., Pieske B. M., Haverkamp1 W., Boldt H. L.,et al. Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure. Heart Fail Rev. 2018; 23(1): 27-36.

[16]	Patel P.A., Ali N., Hogarth A., Tayebjee M.H. Management strategies for atrial fibrillation. Journal of the Royal Society of Medicine. 2017; 110(1): 13-22.

[17]	Hanley C.M., Robinson V.M., Peter R. Kowey P. R. Status of Antiarrhythmic Drug Development for Atrial Fibrillation. New Drugs and New Molecular Mechanisms. Circ. Arrhythm. Electrophysiol. 2016; 9(3):1-9.